Alterations in receptor expression or agonist concentration change the pathways gastrin-releasing peptide receptor

Pei-Wen Chen1, Glenn S Kroog

  • 1Department of Molecular Pharmacology, Albert Eistein College of Medicine, Bronx, New York 10461, USA.

Molecular Pharmacology
|September 14, 2004
PubMed

Insights

Gastrin-releasing peptide receptor (GRPr) activates extracellular signal-regulated kinases (ERKs) through multiple, distinct pathways. These pathways depend on GRPr expression levels and bombesin (BN) concentration, influencing ERK activation and inhibition.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Receptor pharmacology

Background:

  • G protein-coupled receptors (GPCRs) mediate diverse cellular responses.
  • Extracellular signal-regulated kinases (ERKs) are crucial signaling molecules involved in cell growth and differentiation.
  • The gastrin-releasing peptide receptor (GRPr) is a GPCR implicated in various physiological and pathological processes.

Purpose of the Study:

  • To investigate the distinct signaling pathways employed by GRPr to regulate ERK activation.
  • To determine how GRPr expression levels and agonist concentration influence ERK signaling dynamics.
  • To elucidate the mechanisms underlying GRPr-mediated ERK activation and inhibition.

Main Methods:

  • Utilized stably transfected BALB/c 3T3 fibroblasts with varying GRPr expression levels.
  • Administered different concentrations of bombesin (BN), a GRPr agonist.
  • Analyzed ERK activation and inhibition kinetics, including dependence on GRPr carboxyl-terminal domain (CTD) and sensitivity to protein kinase C inhibition.

Main Results:

  • GRPr induced two distinct waves of ERK activation and one wave of ERK inhibition.
  • The first ERK activation wave was CTD-independent, rapid, and sensitive to inhibitors, occurring at lower BN concentrations/GRPr expression.
  • The second ERK activation wave was CTD-dependent, slower, and observed at higher BN concentrations/GRPr expression.
  • A third pathway led to ERK inhibition at high BN concentrations in cells with high GRPr expression.
  • Endogenous GRPr in a human duodenal cancer cell line also exhibited differential pathway activation.

Conclusions:

  • GRPr employs multiple, distinct signaling pathways to regulate ERK activity within a single cell type.
  • The specific pathway utilized is dependent on GRPr expression levels and agonist concentration.
  • These findings reveal a complex regulatory mechanism of ERK signaling by GRPr with implications for understanding cellular responses and potential therapeutic targets.

Related Concept Videos

Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...